Sr. Director
Takeda
Wei Yin, Ph.D., Senior Scientific Director, Quantitative Clinical Pharmacology, Takeda Pharmaceuticals USA. Dr. Yin earned her Ph.D. at the University of Texas at Austin, after which she held positions of increasing responsibility within the biotechnology and pharmaceutical industry settings. She is a senior leader with 20+ years of drug development experience including clinical pharmacology team leader for drugs of multiple modalities (small molecules, biologics, oligonucleotides and gene therapy) in all phases of pre-clinical and clinical development. She has broad experience across a range of therapeutic areas including inflammation, metabolic disease, oncology, rare disease and neuroscience. Over the past 8+ years at Biogen and Takeda she has specialized in neuroscience. Dr. Yin is the author of numerous peer-reviewed articles, invited reviews, and book chapters. She has been a member of professional societies such as Oligonucleotide Therapeutics Society, American Association of Pharmaceutical Scientists and American Society for Clinical Pharmacology and Therapeutics.
Friday, March 24, 2023
1:30 PM – 2:30 PM EDT